Keywords: Glycoprotein P, Methoxy Isobutyl Isonitrile Technetium Tc 99m, Diagnostic Agent, Radiopharmaceutical Agent, Bone Scintiscanning, Cancer Diagnosis, Cancer Staging, Diagnostic Accuracy, Diagnostic Imaging, Follow Up, Human, Letter, Multidrug Resistance, Multiple Myeloma, Priority Journal, Bone Tumor, Clinical Practice, Computer Assisted Tomography, Image Enhancement, Image Subtraction, Metastasis, Methodology, Nuclear Magnetic Resonance Imaging, Positron Emission Tomography, Practice Guideline, Single Photon Emission Computer Tomography, Bone Neoplasms, Physician, S Practice Patterns, Positron-Emission Tomography, Subtraction Technique, Technetium Tc 99m Sestamibi, Emission-Computed, Single-Photon, X-Ray Computed,
Affiliations: *** IBB - CNR ***
Università degli Studi di Napoli Federico II, Naples, Italy
Istituto di Biostrutture e Bioimmagini, CNR, Naples, Italy
Universit degli Studi di Napoli Federico II, Naples, Italy
References: Not available.
Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
Not available.
Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
No results.
Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(879 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote